Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 10/20 | 0.51 |
| ▸ | CYP17A1 | P05093 | 7/20 | 0.49 |
| ▸ | CYP24A1 | Q07973 | 1/20 | 0.45 |
| ▸ | CYP26A1 | O43174 | 1/20 | 0.42 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.41 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5294566 | 0.89 | CYP17A1 (0.49) | CYP19A1CYP17A1CYP24A1CYP26A1 | |
| SCHEMBL5303895 | 0.87 | CYP19A1 (0.55) | CYP19A1CYP17A1CYP24A1CYP26A1CYP11B1 | |
| SCHEMBL5283199 | 0.87 | CYP17A1 (0.51) | CYP19A1CYP17A1CYP24A1CYP26A1 | |
| SCHEMBL5296766 | 0.86 | CYP17A1 (0.47) | CYP19A1CYP17A1CYP24A1 | |
| SCHEMBL5289625 | 0.85 | CYP17A1 (0.46) | CYP19A1CYP17A1CYP24A1 | |
| SCHEMBL5287884 | 0.85 | CYP17A1 (0.46) | CYP19A1CYP17A1CYP24A1 | |
| SCHEMBL5288632 | 0.85 | CYP17A1 (0.46) | CYP19A1CYP17A1CYP24A1 | |
| SCHEMBL5281929 | 0.85 | CYP17A1 (0.46) | CYP19A1CYP17A1CYP24A1 | |
| SCHEMBL5291528 | 0.85 | CYP17A1 (0.46) | CYP19A1CYP17A1CYP24A1 | |
| SCHEMBL5818082 | 0.85 | CYP17A1 (0.46) | CYP19A1CYP17A1CYP24A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2007006418-A1 | IONIC-LIQUID-CONTAINING PRODUCTS FOR DYEING AND/OR BRIGHTENING KERATIN FIBRES | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2007-01-18 | — | — | WO | disclosed |